Page last updated: 2024-08-23

zidovudine and BLV Infections

zidovudine has been researched along with BLV Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afonso, PV; Bangham, CR; Dubreuil, G; Estaquier, J; Gessain, A; Hermine, O; Mahieux, R; Mekaouche, M; Moriceau, A; Mortreux, F; Plumelle, Y; Toulza, F; Wattel, E1
Machuca, A; Rodés, B; Soriano, V1

Trials

1 trial(s) available for zidovudine and BLV Infections

ArticleYear
The effect of antiretroviral therapy on HTLV infection.
    Virus research, 2001, Oct-30, Volume: 78, Issue:1-2

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Deltaretrovirus Infections; DNA, Viral; Drug Therapy, Combination; Female; HIV-1; Human T-lymphotropic virus 1; Human T-lymphotropic virus 2; Humans; Lamivudine; Male; Middle Aged; Proviruses; Time Factors; Treatment Outcome; Viral Load; Zidovudine

2001

Other Studies

1 other study(ies) available for zidovudine and BLV Infections

ArticleYear
Highly active antiretroviral treatment against STLV-1 infection combining reverse transcriptase and HDAC inhibitors.
    Blood, 2010, Nov-11, Volume: 116, Issue:19

    Topics: Animals; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD8-Positive T-Lymphocytes; Deltaretrovirus Infections; Disease Models, Animal; Drug Therapy, Combination; Female; Histone Deacetylase Inhibitors; HTLV-I Infections; Humans; Male; Monkey Diseases; Papio; Paraparesis, Tropical Spastic; Reverse Transcriptase Inhibitors; Simian T-lymphotropic virus 1; T-Lymphocyte Subsets; Valproic Acid; Viral Load; Zidovudine

2010